This article presents an overview of the Top 5 animal health companies in the world. For a detailed overview of the top 20 animal health companies with insights into revenue generated in 2022, read our article Top 20 animal health companies in the world.
5. Covetrus Inc. (NASDAQ:CVET)
Annual Revenue in 2022 (Million USD): 4,300
In 2022, Covetrus Inc. (NASDAQ:CVET), a global leader in animal health technology and services, was acquired by T.P.G. Capital and funds affiliated with Clayton, Dubilier & Rice (CD&R). T.P.G. acquired all outstanding shares of Covetrus Inc. (NASDAQ:CVET) common stock not already owned by CD&R for $21.00 per share in cash, representing an enterprise value of approximately $4 billion.
4. Elanco Animal Health, Inc. (NYSE:ELAN)
Annual Revenue in 2022 (Million USD): 4,410
Elanco Animal Health, Inc.’s (NYSE:ELAN) revenue of $1,057 million was impacted by an estimated $90-$110 million of revenue related to customer purchasing that was shifted from the second quarter into the first due to a commercial ordering blackout period for legacy Bayer’s ERP system. Despite this, Elanco Animal Health, Inc. (NYSE:ELAN) exceeded expectations for the second quarter and first half of 2023 and is on track to return to revenue growth in the second half of the year. As a result, the company is raising its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS.
3. Boehringer Ingelheim
Annual Revenue in 2022 (Million USD): 6,130
Boehringer Ingelheim is a privately held company with over 10,000 employees. The company specializes in animal health, improved health, innovation, bio-pharmaceuticals, pharmaceuticals, research, healthcare, and contract manufacturing.
2. Zoetis Inc. (NYSE:ZTS)
Annual Revenue in 2022 (Million USD): 8,100
Zoetis Inc.’s (NYSE:ZTS) commercial operations are organized and managed across the United States and International segments. The company delivers a diverse portfolio of companion animal and livestock products tailored to local trends and customer needs within these segments.
1. Merck & Co. Inc. (NYSE:MRK)
Annual Revenue in 2022 (Million USD): 59,300
Animal Health sales of Merck & Co. Inc. (NYSE:MRK) were $5.5 billion in 2022. Companion animal product sales were driven by higher demand for BRAVECTO, offset by supply constraints for certain vaccines. In Q1 2023, total worldwide sales of Merck & Co. Inc. (NYSE:MRK) were $14.5 billion, reflecting continued strong performance in oncology and vaccines.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 25 Most Dangerous Animals in the World and the 15 Companies that Test on Animals in 2022.
